Trials / Unknown
UnknownNCT05220644
Management of Pain Respiratory Distress at the End of Life in Newborn Palliative Care in the Delivery Room
Management of Pain Respiratory Distress at the End of Life in Newborn Palliative Care in the
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The newborn feels pain and the newborn at the end of life, in the delivery room, is potentially exposed to pain and respiratory distress. Protocols for the management of end-of-life symptoms in the delivery room are used in current practice with very few validation studies. The protocol used in delivery rooms in Alsace uses fentanyl and midazolam intranasally. It has been used for 3 years and seems to provide satisfactory relief to newborn babies. In doing so, it seems to reassure parents about the quality of support and it seems to meet the expectations of professionals in these anxiety-provoking contexts. Scientific validation of these practices would allow wider dissemination to other maternity teams.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Protocols for the management of end-of-life symptoms | Application of the care protocol and data collection |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-02-01
- Completion
- 2023-02-01
- First posted
- 2022-02-02
- Last updated
- 2022-02-02
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05220644. Inclusion in this directory is not an endorsement.